.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Baxter
Deloitte
Medtronic
Accenture
Chinese Patent Office
Express Scripts
Daiichi Sankyo
Julphar
US Army

Generated: June 22, 2017

DrugPatentWatch Database Preview

Claims for Patent: 9,408,893

« Back to Dashboard

Claims for Patent: 9,408,893

Title:Pharmaceutical combination for use in glycemic control in diabetes type 2 patients
Abstract: The present invention refers to a pharmaceutical combination for use in glycemic control in diabetes type 2 patients.
Inventor(s): Niemoeller; Elisabeth (Frankfurt am Main, DE), Muehlen-Bartmer; Isabel (Frankfurt am Main, DE), Silvestre; Louise (Paris, FR), Boka; Gabor (Paris, FR), Miossec; Patrick (Paris, FR)
Assignee: Sanofi-Aventis Deutschland GMBH (Frankfurt am Main, DE)
Application Number:13/595,590
Patent Claims: 1. A method for improvement of glycemic control in a patient having diabetes type 2, comprising administering to the patient a therapeutically effective amount of the pharmaceutical combination comprising: (a) desPro.sup.36Exendin-4(1-39)-Lys.sub.6-NH.sub.2 and/or a pharmaceutically acceptable salt thereof, and (b) a glitazone and/or a pharmaceutically acceptable salt thereof; and wherein the patient has a haemoglobin A1c (HbA.sub.1c) value of at least 8% and a fasting plasma glucose of at least 9 mmol/L when treated with glitazone alone.

2. The method of claim 1, wherein the patient is an adult.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Merck
UBS
Queensland Health
Daiichi Sankyo
QuintilesIMS
Cantor Fitzgerald
Chinese Patent Office
Novartis
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot